114 views | 11 months ago
Nikoletta Sidiropoulos, MD describes the importance of institutional support to ensure equitable access to biomarker testing to improve cancer patient care. Nikoletta Sidiropoulos is an associate professor...
125 views | 11 months ago
Caterina Marchiò, MD, PhD, spiega perché l'implementazione del test CGP (Comprehensive Genomic Profiling) nel proprio istituto, rispetto all'invio dei campioni a un servizio esterno, può offrire maggiori...
173 views | 11 months ago
Nicole Pfarr, Dipl.-Biol, discusses how tumor whole exome sequencing (WES) can provide valuable insights into mechanisms that drive tumor proliferation, survival, and response to therapy. WES has the...
136 views | 11 months ago
Nicole Pfarr, Dipl.-Biol, discusses how an in-house comprehensive genomic profiling (CGP) including HRD provides fast turnaround to guide patient treatment and improves laboratory operational efficiency....
164 views | 11 months ago
Enrique de Álava, MD, PhD explica los beneficios que aporta utilizar la secuenciación masiva (Next-Generation Sequencing) y oncología de precisión para los pacientes con carcinoma de pulmón. El Dr....
628 views | 11 months ago
Enrique de Álava, MD, PhD discusses the benefits of using NGS panels vs single-gene testing to guide treatment of non-small cell lung cancer patients (NSCLC) and explains the value of comprehensive...
176 views | 11 months ago
Caterina Marchiò, MD, PhD explains the benefits of performing in-house CGP testing vs test send-out to increase the opportunities for precision medicine for cancer patients. Dr. Marchiò presents 3 patient...
413 views | 11 months ago
Illumina presentation recorded at EACR Liquid Biopsies 2024 conference in Lyon. In this brief video (16 min), Anna Babayan outlines solutions available for liquid biopsy research, including Cell-free...